Clinical Trials in North Carolina

Showing 19841-19860 of 20,428 trials

Phase 2 Study of MD-1100 Acetate Administered for 14 Days to Patients Meeting Criteria for Chronic Constipation

NCT00306748

The purpose of this study is to determine the safety and gastrointestinal pharmacodynamics (stool frequency, stool consistency, stool ease of passage, stool completeness of evacuation) of MD-1100 acetate administered daily for 14 days.

Constipation

Ironwood Pharmaceuticals, Inc.40 participantsStarted Mar 2006

Huntsville, Alabama, United States • North Little Rock, Arkansas, United States • Boynton Beach, Florida, United States +11 more locations

COMPLETEDPhase 241 miles

A Long-Term Safety Study of IDEA-033 in Comparison to Oral Naproxen for the Treatment of Osteoarthritis of the Knee

NCT00265304

The purpose of this study is to evaluate the long-term safety of IDEA-033 (an anti-inflammatory pain-relieving drug applied to the skin) in comparison to naproxen (an anti-inflammatory pain-relieving drug taken by mouth) for the treatment of osteoarthritis of both knees.

Osteoarthritis, Knee

IDEA AG550 participantsStarted Jul 2005

Birmingham, Alabama, United States • Montgomery, Alabama, United States • Montgomery, Alabama, United States +90 more locations

Phase 2 Study of MD-1100 Acetate Administered for 14 Days to Patients Meeting Criteria for Chronic Constipation

A Long-Term Safety Study of IDEA-033 in Comparison to Oral Naproxen for the Treatment of Osteoarthritis of the Knee

Find Trials by Condition in North Carolina

NEXIUM® in the Treatment of Moderate and Severe Erosive Esophagitis

Safety & Efficacy Study of Quetiapine Fumarate (SEROQUEL®) vs. Placebo & Active Control in Generalized Anxiety Disorder

Study Comparing STR (Skeletal Targeted Radiotherapy) Plus Melphalan to Melphalan Alone, With Stem Cell Transplant in Multiple Myeloma

Safety & Efficacy Study of Quetiapine Fumarate (SEROQUEL®) vs. Placebo in Generalized Anxiety Disorder

Phase 3 /Seroquel SR Acute Mania Monotherapy - US

Efficacy and Safety of Quetiapine Fumarate Sustained Release (SEROQUEL SR) in Combination With an Antidepressant in the Treatment of Major Depressive Disorders

Study of MEDI-522 Administered by Subcutaneous Injection to Adults With Plaque Psoriasis

Safety and Efficacy Maintenance Study of Quetiapine SR to Treat GAD Patients.

Pharmacokinetic Study of Vildagliptin in Patients With Renal Impairment

Efficacy & Safety of Quetiapine Fumarate (SEROQUEL) & Placebo in the Treatment of Acutely Ill Patients With Schizophrenia

Lofexidine for Inpatient Opiate Detox

Safety, Tolerability, Immunological and Clinical Efficacy of Multiple Subcutaneous Doses of DiaPep277 in Latent Autoimmune Diabetes in Adults (LADA)

Motor-Point Stimulation for Conditioning the Diaphragm of Patients With Amyotrophic Lateral Sclerosis (ALS)

Genetics of Progressive Multifocal Leukoencephalopathy and Acquired Immunodeficiency Syndrome

Safety and Tolerance Study of Oral Doses of CT53518 to Treat Patients With Acute Myelogenous Leukemia (AML)

An International Study of Rimonabant in Dyslipidemia With AtheroGenic Risk In Abdominally Obese Patients

TELI TON - Telithromycin in Tonsillitis

Clopidogrel as Adjunctive Reperfusion Therapy - Thrombolysis in Myocardial Infarction